Kidney Cancer Clinical Trial

Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach

Summary

Patients with renal masses eligible to partial nephrectomy often require arterial ischemia to control or prevent blood loss during this surgical procedure. This study aims to determine the safety and efficacy of renal cryoablation at the tumor bed, as a substitute measure or technique vs total or selective arterial renal ischemia.

View Full Description

Full Description

Nephron sparring surgery has emerged as the procedure of choice for most patients with renal tumors that are >2 cm and harbor a greater than 50% exophitic component. In order to decrease blood loss surgeons may: 1- interrupt blood flow to the kidney, completely or selectively; 2-Use diuretics such as mannitol to dehydrate the kidney; 3-Ice externally the kidney - in open procedures - to decrease metabolism during ischemia.

The emergence of robotic surgery triggered a shift in the the surgical approach to partial nephrectomy and is commonly employed. A fundamental drawback of this technique is represented on the lack of cold ischemia. However, warm ischemia is commonly employed and requires dissection of the renal pedicle, which by itself puts the kidney at risk of loss.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with ages between 45-90-year-old.
Renal tumor ≤ 7 cm in the greatest extension, >50% exophitic.

Exclusion Criteria:

Prior renal surgery
M1 Disease

Study is for people with:

Kidney Cancer

Estimated Enrollment:

150

Study ID:

NCT05218811

Recruitment Status:

Recruiting

Sponsor:

Urological Research Network, LLC

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Urological Research Network
Miami Lakes Florida, 33016, United States More Info
CIELO GUERRA, BS
Contact
305-515-9887
[email protected]
FERNANDO J BIANCO, MD
Principal Investigator
EUSEBIO J LUNA, MD
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

150

Study ID:

NCT05218811

Recruitment Status:

Recruiting

Sponsor:


Urological Research Network, LLC

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider